# US 2017/0253612 A1 · Pyrimidine compounds and pyrimido indole compounds and methods of use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0253612 A1
- Document ID: US20170253612A1
- Status: Published application
- Kind: A1
- Application number: 15/479,752
- Filed: 2017-04-05
- Published: 2017-09-07
- Earliest claimed: 2014-08-08
- Assignees: Duquesne University of the Holy Spirit
- Applicants: Duquesne University of the Holy Spirit
- Inventors: Aleem Gangjee
- Web page: https://patentgrep.com/patent/US20170253612A1

## CPC

- C07D 495/04: Ortho-condensed systems
- A61K 31/343: condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A61K 31/4709: Non-condensed quinolines and containing further heterocyclic rings
- A61K 31/505: Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- C07D 239/48: Two nitrogen atoms
- C07D 403/02: containing two hetero rings
- C07D 405/02: containing two hetero rings
- C07D 487/04: Ortho-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention discloses a compound comprising the formula: wherein R is hydrogen or an alkyl group having from one to ten carbon atoms, or a compound of the formula wherein the S is replaced by CH2, and optionally comprising a pharmaceutically acceptable salt, hydrate, or solvate thereof. A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of the compound or pharmaceutically acceptable salt, hydrate, or solvate thereof.

## Claims

### Claim 1

A compound comprising the formula:
wherein R is selected from one of the following groups consisting of:
and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.

### Claim 2

(canceled)

### Claim 3

A compound comprising the formula:
and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.

### Claim 4

A compound comprising the formula:
wherein R is 2-OCH3, 3-OCH3, 4-OCH3, or 3,4-diOCH3, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.

### Claim 5

A compound comprising the formula:
wherein R is 2-OCH3, 3-OCH3, 4-OCH3, or 3,4-diOCH3, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.

### Claim 6

A compound comprising the formula:
wherein R1 is hydrogen or an alkyl group having from one to ten carbon atoms, R2 is hydrogen or an alkyl group having from one to ten carbon atoms, R3 is hydrogen or an alkyl group having from one to ten carbon atoms, and R4 is hydrogen or an alkyl group having from one to ten carbon atoms, wherein R1, R2, R3, and R4 are independently selected and may be the same or different, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.

### Claim 7

A compound comprising the formula:
wherein R is hydrogen or an alkyl group having from one to ten carbon atoms, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.

### Claim 8

A compound comprising the formula:
wherein R is hydrogen or an alkyl group having from one to ten carbon atoms, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.

### Claim 9

A compound comprising the formula:
and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.

### Claim 10

(canceled)

### Claim 11

A pharmaceutical composition comprising a therapeutically effective amount of a compound of the formula:
wherein R is selected from one of the following groups consisting of:
and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.

### Claim 12

(canceled)

### Claim 13

A pharmaceutical composition comprising a therapeutically effective amount of a compound of the formula:
and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.

### Claim 14

A pharmaceutical composition comprising a therapeutically effective amount of a compound of the formula:
wherein R is 2-OCH3, 3-OCH3, 4-OCH3, or 3,4-diOCH3, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.

### Claim 15

A pharmaceutical composition comprising a therapeutically effective amount of a compound of the formula:
wherein R is 2-OCH3, 3-OCH3, 4-OCH3, or 3,4-diOCH3, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.

### Claim 16

A pharmaceutical composition comprising a therapeutically effective amount of a compound of the formula:
wherein R1 is hydrogen or an alkyl group having from one to ten carbon atoms, R2 is hydrogen or an alkyl group having from one to ten carbon atoms, R3 is hydrogen or an alkyl group having from one to ten carbon atoms, and R4 is hydrogen or an alkyl group having from one to ten carbon atoms, wherein R1, R2, R3, and R4 are independently selected and may be the same or different, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.

### Claim 17

A pharmaceutical composition comprising a therapeutically effective amount of a compound of the formula:
wherein R is hydrogen or an alkyl group having from one to ten carbon atoms, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.

### Claim 18

A pharmaceutical composition comprising a therapeutically effective amount of a compound of the formula:
wherein R is hydrogen or an alkyl group having from one to ten carbon atoms, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.

### Claim 19

A pharmaceutical composition comprising a therapeutically effective amount of a compound of the formula:
and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.

### Claim 20

(canceled)

### Claim 21

A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of a compound comprising formula:
wherein R is selected from one of the following groups consisting of:
and optionally comprising a pharmaceutically acceptable salt or hydrate or solvate thereof, and including administering an effective amount of said salt, hydrate, or solvate of said compound to said patient.

### Claim 22

A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of a compound comprising formula:
and optionally comprising a pharmaceutically acceptable salt or hydrate or solvate thereof, and including administering an effective amount of said salt, hydrate, or solvate of said compound to said patient.

### Claim 23

A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of a compound comprising formula:
and optionally comprising a pharmaceutically acceptable salt or hydrate or solvate thereof, and including administering an effective amount of said salt, hydrate, or solvate of said compound to said patient.

### Claim 24

A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of a compound comprising formula:
wherein R is 2-OCH3, 3-OCH3, 4-OCH3, or 3,4-diOCH3, and optionally comprising a pharmaceutically acceptable salt or hydrate or solvate thereof, and including administering an effective amount of said salt, hydrate, or solvate of said compound to said patient.

### Claim 25

A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of a compound comprising formula:
wherein R is 2-OCH3, 3-OCH3, 4-OCH3, or 3,4-diOCH3, and optionally comprising a pharmaceutically acceptable salt or hydrate or solvate thereof, and including administering an effective amount of said salt, hydrate, or solvate of said compound to said patient.

### Claim 26

A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of a compound comprising formula:
wherein R1 is hydrogen or an alkyl group having from one to ten carbon atoms, R2 is hydrogen or an alkyl group having from one to ten carbon atoms, R3 is hydrogen or an alkyl group having from one to ten carbon atoms, and R4 is hydrogen or an alkyl group having from one to ten carbon atoms, wherein R1, R2, R3, and R4 are independently selected and may be the same or different, and optionally comprising a pharmaceutically acceptable salt or hydrate or solvate thereof, and including administering an effective amount of said salt, hydrate, or solvate of said compound to said patient.

### Claim 27

A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of a compound comprising formula:
wherein R is hydrogen or an alkyl group having from one to ten carbon atoms, and optionally comprising a pharmaceutically acceptable salt or hydrate or solvate thereof, and including administering an effective amount of said salt, hydrate, or solvate of said compound to said patient.

### Claim 28

A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of a compound comprising formula:
wherein R is hydrogen or an alkyl group having from one to ten carbon atoms, and optionally comprising a pharmaceutically acceptable salt or hydrate or solvate thereof, and including administering an effective amount of said salt, hydrate, or solvate of said compound to said patient.

### Claim 29

A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of a compound comprising formula:
and optionally comprising a pharmaceutically acceptable salt or hydrate or solvate thereof, and including administering an effective amount of said salt, hydrate, or solvate of said compound to said patient.

### Claim 30

A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of a compound comprising formula:
wherein R is hydrogen, an alkyl group having from one to ten carbon atoms, NH2, I, or CN, and optionally comprising a pharmaceutically acceptable salt or hydrate or solvate thereof, and including administering an effective amount of said salt, hydrate, or solvate of said compound to said patient.

### Claim 31

(canceled)
